STANDARD BIOTOOLS INC.

Analyst Reco. Standard BioTools Inc.

Equities

LAB

US34385P1084

Market Closed - Nasdaq Other stock markets 04:00:03 2024-04-23 pm EDT			5-day change	1st Jan Change
2.565 ^USD	+0.98%		-5.35%	+16.06%

Apr. 16	TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	MT
Apr. 08	Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	Apr. 16	MT
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target	Apr. 04	MT
KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology	23-07-12	MT
BTIG Adjusts Fluidigm's Price Target to $10 From $12, Reiterates Buy Rating	21-12-16	MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $9 From $10, Reiterates Buy Rating	21-02-11	MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $10 From $15, Citing Lower Revenue Forecasts for COVID Testing Business; Buy Rating Kept	21-01-07	MT
FLUIDIGM : Piper Sandler Adjusts Fluidigm's Price Target to $15 from $12, Maintains Overweight Rating	20-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer